Impact of a Donor Age >75 Years on the Survival of Liver Transplant Recipients |
| |
Affiliation: | 1. Liver transplantation Unit, Gastroenterology Department, Hospital Universitario Rio Hortega, Valladolid, Spain;2. Department of Pathology, Hospital Universitario Rio Hortega, Valladolid, Spain;1. Department of Nephrology, Hospital Puerta del Mar, Cadiz, Spain;2. Department of Nephrology, Hospital Jerez de la Frontera, Cadiz, Spain;3. Department of Microbiology, Hospital Puerta del Mar, Cadiz, Spain;1. Heart Failure and Transplantation Unit, La Fe University and Polytechnic Hospital, Valencia, Spain;2. Department of Cardiology, La Fe University and Polytechnic Hospital, Valencia, Spain;3. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Spain;4. Department of Medicine, Universidad de Valencia, Valencia, Spain |
| |
Abstract: | BackgroundAn organ shortage is the reason why it is necessary to expand the pool of donors, which can be achieved by using elderly donors. The main goal of this study is to analyze the outcomes of liver transplant (LT) when it is performed with donors older than 75 years.MethodsWe carried out a retrospective case-control study (N = 212) that included LTs with donors older than 75 years (group A, n = 106 cases) that were performed in our center between the years 2010 and 2020. This cohort has been paired off with a similar control group (group B, n = 106) whose donors were significantly younger. A survival analysis using the Kaplan-Meier model was performed.ResultsAverage (SD) age of donors in group A was statistically greater than group B (A, 79.1 [3.0] years vs B, 54.4 [15.3], P < .001). There were no differences either in the average age of the recipients or in the Model for End-Stage Liver Disease score of both groups. Indications for LT were distributed equally in both groups: the most common was cellular hepatocarcinoma followed by alcohol-related cirrhosis. Survival rates for group A were 81%, 78%, and 67%, in 1, 3, and 5 years, respectively, while in group B they were 85%, 76%, and 71%, respectively, without differences found between the groups (P = .57).ConclusionsUsing elderly liver donors is safe, achieving good outcomes in terms of short- and midterm rates of survival. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|